Filing Details

Accession Number:
0001209191-22-041835
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-11 17:24:11
Reporting Period:
2022-07-11
Accepted Time:
2022-07-11 17:24:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660334 Verrica Pharmaceuticals Inc. VRCA Pharmaceutical Preparations (2834) 463137900
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1805359 G. Christopher Hayes C/O Verrica Pharmaceuticals Inc.
44 West Gay Street, Suite 400
West Chester PA 19380
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-11 7,500 $3.40 15,714 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct